Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Non-cash Items (2016 - 2017)

Bone Biologics (BBLG) has disclosed Non-cash Items for 2 consecutive years, with $1.2 million as the latest value for Q2 2017.

  • On a quarterly basis, Non-cash Items fell 58.23% to $1.2 million in Q2 2017 year-over-year; TTM through Jun 2017 was $1.2 million, a 58.23% decrease, with the full-year FY2016 number at $4.4 million, changed N/A from a year prior.
  • Non-cash Items was $1.2 million for Q2 2017 at Bone Biologics, down from $1.3 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $4.4 million in Q4 2016 to a low of $557544.0 in Q1 2016.